APA (7th ed.) Citation

Hallow, K. M., Helmlinger, G., Greasley, P. J., McMurray, J. J. V., & Boulton, D. W. (2018). Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis. Diabetes, obesity & metabolism, 20(3), 479-487. https://doi.org/10.1111/dom.13126

Chicago Style (17th ed.) Citation

Hallow, Karen M., Gabriel Helmlinger, Peter J. Greasley, John J. V. McMurray, and David W. Boulton. "Why Do SGLT2 Inhibitors Reduce Heart Failure Hospitalization? A Differential Volume Regulation Hypothesis." Diabetes, Obesity & Metabolism 20, no. 3 (2018): 479-487. https://doi.org/10.1111/dom.13126.

MLA (9th ed.) Citation

Hallow, Karen M., et al. "Why Do SGLT2 Inhibitors Reduce Heart Failure Hospitalization? A Differential Volume Regulation Hypothesis." Diabetes, Obesity & Metabolism, vol. 20, no. 3, 2018, pp. 479-487, https://doi.org/10.1111/dom.13126.